These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9284415)

  • 1. [Genetically engineered mice for study of human hypertension].
    Sugiyama F; Taniguchi K; Fukamizu A; Yagami K
    Nihon Rinsho; 1997 Aug; 55(8):2005-10. PubMed ID: 9284415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of genetically engineered mice with hypertension and hypotension.
    Sugiyama F
    Exp Anim; 1997 Jul; 46(3):171-82. PubMed ID: 9250477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on the etiology of hypertension--summarizing studies in 20th century. 2. Genetic engineering in hypertension research.
    Kurihara H
    Intern Med; 2001 Feb; 40(2):147-51. PubMed ID: 11300150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gene mutation and polymorphism as risk factors in the development of hypertensive organ damage].
    Okura T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():92-7. PubMed ID: 15171348
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of hypertension therapy: sense, antisense, or nonsense?
    Pachori AS; Huentelman MJ; Francis SC; Gelband CH; Katovich MJ; Raizada MK
    Hypertension; 2001 Feb; 37(2 Pt 2):357-64. PubMed ID: 11230300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of primary hypertension.
    Ganten D; Schmidt S; Paul M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S45-50. PubMed ID: 7700065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic renal mechanisms of hypertension.
    Cusi D
    Curr Opin Nephrol Hypertens; 1997 Mar; 6(2):192-8. PubMed ID: 9146983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene targeting approaches to analyzing hypertension.
    Takahashi N; Smithies O
    J Am Soc Nephrol; 1999 Jul; 10(7):1598-605. PubMed ID: 10405217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically altered animal models in the kallikrein-kinin system.
    Pesquero JB; Bader M
    Biol Chem; 2006 Feb; 387(2):119-26. PubMed ID: 16497143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic markers of hypertension].
    Chistiakov DA; Turakulov RI
    Genetika; 1999 May; 35(5):565-73. PubMed ID: 10495944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for hypertension.
    Paulis L; Franke H; Simko F
    Expert Opin Biol Ther; 2017 Nov; 17(11):1345-1361. PubMed ID: 28780894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The genetics of intermediate phenotypes in hypertension].
    Koshechkina EV
    Ter Arkh; 1995; 67(4):59-61. PubMed ID: 7784981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution of rennin-angiotensin-aldosterone system genes and NO synthase gene to the development of arterial hypertension].
    Savinetskaia GA; Golubeva AA; Pogoda TV; Generozov EV
    Klin Med (Mosk); 2008; 86(8):12-7. PubMed ID: 18819340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic animals in hypertension and cardiovascular research.
    Brosnan MJ; Mullins JJ
    Exp Nephrol; 1993; 1(1):3-12. PubMed ID: 8081950
    [No Abstract]   [Full Text] [Related]  

  • 15. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
    Stasch JP; Knorr A; Hirth-Dietrich C; Krämer T; Hübsch W; Dressel J; Fey P; Beuck M; Sander E; Frobel K; Kazda S
    Arzneimittelforschung; 1997 Sep; 47(9):1016-23. PubMed ID: 9342414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system.
    Ribeiro JM; Santos RA; Pesquero JB; Bader M; Krieger EM
    Regul Pept; 2005 Jul; 129(1-3):155-9. PubMed ID: 15927711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-angiotensin system in transgenic rats: characteristics and functional studies.
    Wagner J; Ganten D
    Semin Nephrol; 1993 Nov; 13(6):586-92. PubMed ID: 8278693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypotensive effect of encapsulated genetically engineered fibroblasts expressing mutant atrial natriuretic peptide in hypertensive rats].
    Li T; Liang H; Lu G; Shi R; Lu S
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1086-9. PubMed ID: 12425814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental genetic modifications in the renin-angiotensin and kallikrein-kinin systems: significance for understanding cardiovascular regulation and study of genetic determinism of human diseases].
    Meneton P; Alhenc-Gelas F
    Nephrologie; 1998; 19(7):385-9. PubMed ID: 9857372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.